Loading company…
Opella develops and sells over-the-counter medicines and vitamins, minerals, and supplements.
Opella is Sanofi's consumer healthcare business, with a portfolio of more than 100 brands, 13 manufacturing sites, and four science and innovation development centers across 100 countries. Its products include Allegra, Doliprane, and Dulcolax. Based in Neuilly-sur-Seine, France, it is led by CEO Julie Van Ongevalle. In October 2024, Clayton Dubilier & Rice agreed to acquire a 50% controlling stake from Sanofi in a transaction valuing the company at EUR 16 billion, expected to close in the second quarter of 2025.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign inWork at Opella Healthcare Group SAS? This is my company